Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant.
about
MHC class I signaling: new functional perspectives for an old moleculeDetection of HLA Antibodies in Organ Transplant Recipients - Triumphs and Challenges of the Solid Phase Bead AssayAn update on the impact of pre-transplant transfusions and allosensitization on time to renal transplant and on allograft survivalEarly acute antibody-mediated rejection of a negative flow crossmatch 3rd kidney transplant with exclusive disparity at HLA-DP.Accommodation in renal transplantation: unanswered questions.The Induction of IgM and IgG Antibodies against HLA or MICA after Lung Transplantation.Interlaboratory Comparison of the Results of Lifecodes LSA Class I and Class II Single Antigen Kits for Human Leukocyte Antigen Antibody DetectionApplication of calculated panel reactive antibody using HLA frequencies in Koreans.Clinical relevance of pretransplant HLA class II donor-specific antibodies in renal transplantation patients with negative T-cell cytotoxicity crossmatches.Utility of HLA Antibody Testing in Kidney Transplantation.The impact of pretransplant donor-specific antibodies on graft outcome in renal transplantation: a six-year follow-up study.Monitoring of CD4+CD25highIL-7Rαhigh activated T cells in kidney transplant recipients.Lymphocyte Activation Markers in Pediatric Kidney Transplant RecipientsDonor-specific antibodies adversely affect kidney allograft outcomes.Calculated PRA (CPRA): the new measure of sensitization for transplant candidates.Monitoring tolerance and rejection in organ transplant recipients.Detection of anti-HLA antibodies by solid-phase assay in kidney transplantation: friend or foe?Luminex and antibody detection in kidney transplantation.Clinical relevance of antibody development in renal transplantation.Assessing immunologic risk factors in transplantation.Clinical significance of the presence of anti-human leukocyte antigen-donor specific antibody in kidney transplant recipients with allograft dysfunction.Follicular T helper cells and humoral reactivity in kidney transplant patients.Pre-transplant low level HLA antibody shows a composite poor outcome in long-term outcome of renal transplant recipients.Antibodies in transplantation: the effects of HLA and non-HLA antibody binding and mechanisms of injury.Complement-dependent cytotoxicity and Luminex technology for human leucocyte antigen antibody detection in kidney transplant candidates exposed to different sensitizing events.Clinical Significance of Pretransplant Donor-Specific Antibodies in the Setting of Negative Cell-Based Flow Cytometry Crossmatching in Kidney Transplant Recipients.Determining donor-specific antibody C1q-binding ability improves the prediction of antibody-mediated rejection in human leucocyte antigen-incompatible kidney transplantation.Heart transplant with donor-specific antibody after immunoadsorption plus rituximab: a case report.Dynamic challenges inhibiting optimal adoption of kidney paired donation: findings of a consensus conference.Tracing clinically relevant HLA antibodies prior to kidney transplantation: Commentary on "Pre-transplant HLA antibodies detected by single antigen bead assay are a risk factor for long-term kidney graft loss even in the absence of donor specific an
P2860
Q27000194-3F722003-ADBD-404F-AB4F-F545FEB0D5E7Q28075921-98E35F92-C1CF-4A7A-8A2C-7C181886AA9EQ30586178-6FAE78ED-979D-4335-9675-3CD9B0CB9D2BQ33993707-07A5DCB0-497C-4B72-A53C-50A5E12A61EAQ34903473-98DF8AC7-11A2-4519-9492-E550F8DCE1F7Q35195122-CC6D1895-C6DA-43D0-8F78-A727C52CA4F9Q35332072-AB185623-AEA0-4DCB-8A26-FA0579B97049Q35664894-CA02AE39-6B5B-4591-9467-7B0DDC5DF8D5Q35788603-6433CC47-062C-4EEB-85D2-4962700E9A57Q35790601-E1356D4B-2EDE-4AE5-B230-2F386BAB0886Q35865046-1A6E4C5E-C22F-4498-9C2C-68168A433FEDQ35985731-25E0149D-783E-45A1-B2C1-F458A30FF827Q36186406-5C91999F-28DC-49C9-B24E-176D7ED9EADEQ36426146-1FD8DAF0-FB5D-4414-8DC8-6F9C44E7B6A2Q37643767-53F7ACD8-37E7-408D-A405-0047950EF2F5Q37894733-DA368FA8-F922-4233-8E3B-22DF94A0A0DCQ38001495-69A9B106-6506-44A9-A09A-31A9A01E0A91Q38007085-7A64E832-D0AF-4AA8-80A4-D79057786A8EQ38079301-EEFD5223-7931-4D64-B0F1-EDA0A148CA3BQ38131035-EB25C7D7-16BF-4820-BAFE-BF971D5F1D4AQ38409644-DE6FC05E-D9AB-45CC-9C68-95CA00AA74C0Q38923388-CA323F1B-8DB7-444F-97EB-1AD71492D43CQ41615009-6B6B994E-14AA-472E-A0B1-D6EDD068C7E7Q41849097-DBF2B92D-62C5-4F55-B4AE-FAFB18BDBF44Q47167963-E067F057-4E7B-493A-8C08-0F867648D631Q47313617-9DC02F7D-0FE7-4A57-B0CC-440DDD03E821Q48255248-57946806-682C-4DB5-BF3C-92E697485622Q50894315-9BBE0284-C271-47F5-812E-E6AAD9D54C04Q51260684-77618387-EB88-411E-9A67-FEF23223CBB3Q52852316-4BC51E5A-0E11-45E4-963E-8ECFBE932DC7
P2860
Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Low levels of human leukocyte ...... quently clinically irrelevant.
@en
Low levels of human leukocyte ...... quently clinically irrelevant.
@nl
type
label
Low levels of human leukocyte ...... quently clinically irrelevant.
@en
Low levels of human leukocyte ...... quently clinically irrelevant.
@nl
prefLabel
Low levels of human leukocyte ...... quently clinically irrelevant.
@en
Low levels of human leukocyte ...... quently clinically irrelevant.
@nl
P2093
P1433
P1476
Low levels of human leukocyte ...... quently clinically irrelevant.
@en
P2093
Jean-Pierre Venetz
Manuel Pascual
Vincent Aubert
P304
P356
10.1016/J.HUMIMM.2009.04.011
P577
2009-04-16T00:00:00Z